Icagen Reports Third Quarter 2008 Financial Results
06 nov. 2008 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the third quarter ended September 30,...
Icagen to Present at Rodman & Renshaw 10th Annual Healthcare Conference on November 10, 2008
03 nov. 2008 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 3, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the Rodman & Renshaw 10th Annual Healthcare...
Icagen to Report Third Quarter 2008 Results On November 6, 2008
30 oct. 2008 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release third quarter 2008 financial results on Thursday, November 6, 2008 before...
Icagen to Present at Seventh Annual BIO Investor Forum on October 29, 2008
22 oct. 2008 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 22, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the Seventh Annual BIO Investor Forum to be...
Icagen Initiates Phase II Proof-of-Concept Trial in Allergic Asthma for Senicapoc Potassium Channel Blocker
09 oct. 2008 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) announced today the start of a Phase II proof-of-concept clinical trial to evaluate the safety and efficacy of...
Icagen Announces Presentation Related to Senicapoc At the 15th International Inflammation Research Association Conference
22 sept. 2008 17h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 22, 2008 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today, at the 15th International Inflammation Research Association Conference in Chantilly,...
Icagen Reports Second Quarter 2008 Financial Results
05 août 2008 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 5, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the second quarter ended June 30, 2008....
Icagen Successfully Completes Phase I Multiple Ascending Dose Clinical Trial of Senicapoc
09 juil. 2008 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., July 9, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported that the Company successfully completed the Phase I multiple ascending dose clinical trial of...
Icagen to Present At the Collins Stewart Fourth Annual Growth Conference On July 10, 2008
26 juin 2008 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., June 26, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the Collins Stewart Fourth Annual Growth...
Icagen to Present At the Rodman & Renshaw 5th Annual Global Healthcare Conference On May 19, 2008
12 mai 2008 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., May 12, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the Rodman & Renshaw 5th Annual Global...